Cancer Treatment Reviews
Volume 31, Issue 3 , Pages 230-235 , May 2005

Brachytherapy improved dysphagia more than stenting in people with inoperable oesophageal cancer: Abstracted from: Homs MYV, Steyerberg EW, Eijkenboom WMH et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: a multicentre randomised trial. Lancet 2004;364:1497–504

References 

  1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. Eur J Cancer. 2001;37:S4–S66
  2. O’Rourke IC, McNeil RJ, Walker PJ, Bull CA. Objective evaluation of the quality of palliation in patients with oesophageal cancer comparing surgery, radiotherapy and intubation. Aust NZ J Surg. 1992;62:922–930
  3. O’Rourke IC, Tiver K, Bull C, Gebski V, Langlands AO. Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer. 1988;61:2022–2026
  4. Reed CE, Marsh WH, Carlson LS, Seymore CH, Kratz JM. Prospective, randomized trial of palliative treatment for unresectable cancer of the esophagus. Ann Thorac Surg. 1991;51:552–555[discussion]
  5. Schmid EU, Albert AS, Greeff F, et al. The value of radiotherapy or chemotherapy after intubation for advanced esophageal carcinoma – a prospective randomzied trial. Radiotherapy Oncol. 1993;28:27–30
  6. Sargeant IR, Tobias JS, Blackman G, et al. Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study. Gut. 1997;40:362–369
  7. Kharadi MY, Qadir A, Khan FA, Khuroo MS. Comparative evaluation of therapeutic approaches in stageIIIandIVsquamous cell carcinoma of the thoracic esophagus with conventional radiotherapy and endoscopic treatment in combination and endoscopic treatment alone: a randomized prospective trial. Int J Radiat Oncol Biol Phys. 1997;39:309–320
  8. Kolaric K, Maricic Z, Roth A, Dujmovic I. Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer: a randomized study. Cancer. 1980;45:2265–2273
  9. Adam A, et al. Palliation of inoperable esopahgeal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology. 1997;202:344–348
  10. Knyrim K, Wagner H, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med. 1993;329:1302–1307
  11. De Palma G, di Matteo E, Romano G, et al. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc. 1996;43:473–482
  12. Siersema PD, Hop W, Dees J, Tilanus HW, van Blankenstein M. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc. 1998;47:113–120
  13. Sanyika C, Corr P, Haffejee A. Palliative treatment of esophageal carcinoma – efficacy of plastic versus self-expandable stents. S Afr Med J. 1999;89:640–643
  14. Conio M, Sorbi D. Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Gastrointest Endosc. 2000;51:248–249
  15. O’Donnell CA, Fullarton GM, Watt E, et al. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg. 2002;89:985–992
  16. Sabharwal T, et al. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003;52:922–926
  17. Low DE, Pagliero KM. Prospective randomized clinical trial comparing brachytherapy and laser photoablation for palliation of esophageal cancer. J Thorac Cardiovasc Surg. 1992;104:173–178discussion 178–9
  18. Sander R, Hagenmueller F, Sander C, Riess G, Classen M. Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: a prospective, randomized, and controlled study. Gastrointest Endosc. 1991;37:433–440
  19. Tan CC, Freeman JG, Holmes GK, Benghiat A. Laser therapy combined with brachytherapy for the palliation of malignant dysphagia. Singapore Med J. 1998;39:202–207
  20. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;40:447–453
  21. Sur RK, et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma – an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53:127–133
  22. Wong R, Malthaner R. Esophageal cancer: a systematic review. Current Problems Cancer. 2000;24:293–376
  23. Homs MY, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dypshagia from oesophageal cancer: multicenter randomised trial. Lancet. 2004;364:1497–1504
  24. Homs MY, et al. Quality of life after palliative treatment for oesophageal carcinoma – a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer. 2004;40:1862–1871

  25. The role of teletherapy (TT) supplementary to intraluminal high dose rate (ILHDR) brachytherapy (BT) in the palliation of advanced oesophageal cancer (E33021). Available from: http://www-crp.iaea.org/ (Searched Jan 2005).

  26. A randomized phase III study in advanced oesophageal cancer to compare palliation of dysphagia in patients treated with radiotherapy versus chemo-radiotherapy (TROG 03.01/ NCIC CTG ES2). Available from: http://www.ranzcr.edu.au, http://www.ctg.queensu.ca/ (Searched Jan 2005).

☆ Sources of funding: Healthcare Insurance Council, Netherlands.

☆☆ For correspondence: Dr Peter D Siersema, Department of Gastroenterology and Hepatology, Erasmus MC/University Medical Centre, Rotterdam, P.O. Box 2040, 2000 CA Rotterdam, The Netherlands. E-mail: p.siersema@erasmusmc.nl.

☆☆☆ Abstract provided by Bazian Ltd, London.

PII: S0305-7372(05)00052-6

doi: 10.1016/j.ctrv.2005.03.002

Cancer Treatment Reviews
Volume 31, Issue 3 , Pages 230-235 , May 2005

Article Tools